• Login
    View Item 
    •   Home
    • The Christie Research Publications Repository
    • All Christie Publications
    • View Item
    •   Home
    • The Christie Research Publications Repository
    • All Christie Publications
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of ChristieCommunitiesTitleAuthorsIssue DateSubmit DateSubjectsThis CollectionTitleAuthorsIssue DateSubmit DateSubjects

    My Account

    LoginRegister

    Local Links

    The Christie WebsiteChristie Library and Knowledge Service

    Statistics

    Display statistics

    Impact on quality of life from multimodality treatment for lung cancer: a randomised controlled feasibility trial of surgery versus no surgery as part of multimodality treatment in potentially resectable stage III-N2 NSCLC (the PIONEER trial)

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Thumbnail
    Name:
    34266853.pdf
    Size:
    560.9Kb
    Format:
    PDF
    Description:
    From UNPAYWALL
    Download
    Authors
    Taylor, Sally
    Yorke, Janelle
    Tsim, S.
    Navani, N.
    Baldwin, D.
    Woolhouse, I.
    Edwards, J.
    Grundy, S.
    Robson, J.
    Rhodes, S.
    Gomes, Fabio
    Blackhall, Fiona H
    Faivre-Finn, Corinne
    Evison, M.
    Show allShow less
    Affiliation
    Christie Patient Centred Research, The Christie NHS Foundation Trust, Manchester, UK
    Issue Date
    2021
    
    Metadata
    Show full item record
    Abstract
    Introduction: Optimal treatment for 'potentially resectable' stage III-N2 non-small cell lung cancer (NSCLC) requires multimodality treatment: local treatment (surgery or radiotherapy) and systemic anticancer therapy. There is no clear evidence of superiority for survival between the two approaches and little research has explored quality of life (QOL). This study will inform the design of a phase III randomised trial of surgery versus no surgery as part of multimodality treatment for stage III-N2 NSCLC with QOL as a primary outcome. Methods and analysis: Patient participants will be randomised to receive multimodality treatment (1) with surgery OR (2) without surgery. The Quintet Recruitment Intervention will be used to maximise recruitment. Eligible patients will have 'potentially resectable' N2 NSCLC and have received a multidisciplinary team recommendation for multimodality treatment. Sixty-six patients and their carers will be recruited from 8 UK centres. Patient/carer QOL questionnaires will be administered at baseline, weeks 6, 9, 12 and month 6. Semistructured interviews will be conducted. Quantitative data will be analysed descriptively and qualitative data will be analysed using framework analysis.
    Citation
    Taylor S, Yorke J, Tsim S, Navani N, Baldwin D, Woolhouse I, et al. Impact on quality of life from multimodality treatment for lung cancer: a randomised controlled feasibility trial of surgery versus no surgery as part of multimodality treatment in potentially resectable stage III-N2 NSCLC (the PIONEER trial). BMJ Open Resp Res. 2021 Jul;8(1):e000846.
    Journal
    BMJ Open Respiratory Research
    URI
    http://hdl.handle.net/10541/624444
    DOI
    10.1136/bmjresp-2020-000846
    PubMed ID
    34266853
    Additional Links
    https://dx.doi.org/10.1136/bmjresp-2020-000846
    Type
    Article
    Language
    en
    ae974a485f413a2113503eed53cd6c53
    10.1136/bmjresp-2020-000846
    Scopus Count
    Collections
    All Christie Publications

    entitlement

    Related articles

    • Stage III Non-small Cell Lung Cancer: A UK National Survey of Practice.
    • Authors: Evison M, Edwards J, McDonald F, Popat S
    • Issue date: 2020 Aug
    • Study protocol for VIdeo assisted thoracoscopic lobectomy versus conventional Open LobEcTomy for lung cancer, a UK multicentre randomised controlled trial with an internal pilot (the VIOLET study).
    • Authors: Lim E, Batchelor T, Shackcloth M, Dunning J, McGonigle N, Brush T, Dabner L, Harris R, Mckeon HE, Paramasivan S, Elliott D, Stokes EA, Wordsworth S, Blazeby J, Rogers CA, VIOLET Trialists
    • Issue date: 2019 Oct 14
    • Surgery as a Component of Multimodality Care for Known Stage IIIA-N2 Non-small Cell Lung Cancer.
    • Authors: Bograd AJ, Vallières E
    • Issue date: 2020 Jun
    • Immunotherapy (excluding checkpoint inhibitors) for stage I to III non-small cell lung cancer treated with surgery or radiotherapy with curative intent.
    • Authors: Zhu J, Li R, Tiselius E, Roudi R, Teghararian O, Suo C, Song H
    • Issue date: 2017 Dec 16
    • Advances in the use of surgery and multimodality treatment for N2 non-small cell lung cancer.
    • Authors: Van Schil PE, Yogeswaran K, Hendriks JM, Lauwers P, Faivre-Finn C
    • Issue date: 2017 Jun
    DSpace software (copyright © 2002 - 2023)  DuraSpace
    Quick Guide | Contact Us
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.